REFERENCES
1. Walker KG, Wilmshurst JM. An update on the treatment of Sydenham’s
chorea: the evidence for established and evolving interventions.
Therapeutic advances in neurological disorders. 2010 Sep;3(5):301-9.
2. Illan Ramos M, Sagastizabal Cardelus B, Garcia Ron A, Guillen Martin
S, Berzosa Sanchez A, Ramos Amador JT. Chorea as the presenting feature
of acute rheumatic fever in childhood; case reports from a
low-prevalence European setting. BMC Infectious Diseases. 2021
Dec;21:1-5.
3. Punukollu M, Mushet N, Linney M, Hennessy C, Morton M.
Neuropsychiatric manifestations of Sydenham’s chorea: a systematic
review. Developmental Medicine & Child Neurology. 2016 Jan;58(1):16-28.
4. Auala T, Zavale BL, Mbakwem AÇ, Mocumbi AO. Acute rheumatic fever and
rheumatic heart disease: Highlighting the role of group A streptococcus
in the global burden of cardiovascular disease. Pathogens. 2022 Apr
21;11(5):496.
5. World Health Organization. Rheumatic fever and rheumatic heart
disease. Report by the Director General. Seventy-First World Health
Assembly World Health Organization, Geneva, Switzerland. 2018.
6. Negi PC, Sondhi S, Asotra S, Mahajan K, Mehta A. Current status of
rheumatic heart disease in India. Indian heart journal. 2019 Jan
1;71(1):85-90.
7. Watkins D, Daskalakis A. The economic impact of rheumatic heart
disease in developing countries. The Lancet Global Health. 2015 Mar
1;3:S37.
8. Coffey PM, Ralph AP, Krause VL. The role of social determinants of
health in the risk and prevention of group A streptococcal infection,
acute rheumatic fever and rheumatic heart disease: a systematic review.
PLoS neglected tropical diseases. 2018 Jun 13;12(6):e0006577.